Search clinical trials for: GenSci004

Total 5 results

Changchun GeneScience Pharmaceutical Co., Ltd.
West China Hospital

Not yet recruiting

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Systemic Sclerosis Associated Interstitial Lung Disease | Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD) | Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

China
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency (ELEVATE)

GHD

United States
Changchun GeneScience Pharmaceutical Co., Ltd.
Afﬁliated Hospital of North Sichuan Medical College

Recruiting

The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site

Infertility

China
Changchun GeneScience Pharmaceutical Co., Ltd.
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (ANGAS)

Infertility

China
GeneScience Pharmaceuticals Co., Ltd.

Recruiting

Safety & Efficacy of Genakumab in Patients With Frequent Flares

Acute Gout

China

3

Subscribe